MedPath

Urea 39% Cream

UREA CREAM 39%

Approved
Approval ID

e79004b9-ffbc-3d06-e053-2995a90a8cd7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 6, 2024

Manufacturers
FDA

BioComp Pharma, Inc.

DUNS: 829249718

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Urea 39% Cream

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code44523-801
Product Classification
G
Generic Name
Urea 39% Cream
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 6, 2024
FDA Product Classification

INGREDIENTS (11)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
CARBOMER INTERPOLYMER TYPE A (55000 CPS)Inactive
Code: 59TL3WG5CO
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
UREAActive
Quantity: 390 mg in 1 g
Code: 8W8T17847W
Classification: ACTIB
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
DIMETHYL ISOSORBIDEInactive
Code: SA6A6V432S
Classification: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/23/2022

BCP UREA 39% Cream

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 9/23/2022

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 9/23/2022

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

LOINC: 34083-6Updated: 9/23/2022

Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 9/23/2022

To reporta serious adverse event or obtain product information, call (866) 762-2365.

Manufactured for:
BIOCOMP PHARMA, INC.
San Antonio, TX 78230 1355

2100669 [00] R1021

DESCRIPTION SECTION

LOINC: 34089-3Updated: 9/23/2022

This product is a keratolytic emollient which is a gentle, yet potent, tissue softener for skin.

Each gram contains 390 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, sodium hydroxide, water, and xanthan gum.

Urea is a diamide of carbonic acid with the following chemical structure:

Structure

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 9/23/2022

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 9/23/2022

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

PHARMACOKINETICS SECTION

LOINC: 43682-4Updated: 9/23/2022

The mechanism of action of topically applied urea is not yet known.

WARNINGS SECTION

LOINC: 34071-1Updated: 9/23/2022

KEEP OUT OF REACH OF CHILDREN.

INFORMATION FOR PATIENTS SECTION

LOINC: 34076-0Updated: 9/23/2022

Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or
elsewhere. Avoid contact with eyes, lips and mucous membranes.

PREGNANCY SECTION

LOINC: 42228-7Updated: 9/23/2022

Category C.Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

NURSING MOTHERS SECTION

LOINC: 34080-2Updated: 9/23/2022

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 9/23/2022

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 9/23/2022

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to
temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 9/23/2022

8 oz. (227 g) bottles, NDC 44523-801-08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.